Barclays PLC purchased a new position in shares of Bowhead Specialty Holdings Inc. (NYSE:BOW - Free Report) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 17,082 shares of the company's stock, valued at approximately $479,000. Barclays PLC owned 0.05% of Bowhead Specialty at the end of the most recent quarter.
Several other hedge funds also recently added to or reduced their stakes in the company. Point72 Asset Management L.P. purchased a new stake in Bowhead Specialty in the second quarter worth $117,000. MetLife Investment Management LLC purchased a new position in Bowhead Specialty in the 3rd quarter worth about $123,000. Sandia Investment Management LP bought a new stake in Bowhead Specialty during the 2nd quarter valued at about $127,000. New Vernon Investment Management LLC purchased a new stake in Bowhead Specialty in the 3rd quarter valued at about $127,000. Finally, Quantbot Technologies LP bought a new position in Bowhead Specialty in the 3rd quarter worth about $157,000.
Analysts Set New Price Targets
BOW has been the topic of several research reports. Royal Bank of Canada raised their price objective on Bowhead Specialty from $32.00 to $35.00 and gave the stock an "outperform" rating in a report on Wednesday, November 6th. JMP Securities lifted their price objective on Bowhead Specialty from $32.00 to $33.00 and gave the company a "market outperform" rating in a report on Wednesday, November 6th. JPMorgan Chase & Co. increased their target price on shares of Bowhead Specialty from $26.00 to $30.00 and gave the stock a "neutral" rating in a report on Thursday, November 7th. Finally, Keefe, Bruyette & Woods boosted their price target on shares of Bowhead Specialty from $35.00 to $36.00 and gave the company a "market perform" rating in a report on Wednesday, December 4th. Three equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of "Hold" and an average target price of $32.00.
Check Out Our Latest Report on Bowhead Specialty
Insider Transactions at Bowhead Specialty
In related news, Director Family Mutual Insuran American sold 1,362,285 shares of the business's stock in a transaction on Friday, October 25th. The shares were sold at an average price of $27.70, for a total transaction of $37,735,294.50. Following the completion of the transaction, the director now directly owns 4,700,761 shares in the company, valued at $130,211,079.70. The trade was a 22.47 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink.
Bowhead Specialty Price Performance
BOW traded down $0.49 on Friday, hitting $33.85. The company had a trading volume of 97,455 shares, compared to its average volume of 141,827. The stock has a fifty day moving average price of $34.28 and a 200-day moving average price of $30.21. Bowhead Specialty Holdings Inc. has a 12-month low of $22.14 and a 12-month high of $37.81.
Bowhead Specialty (NYSE:BOW - Get Free Report) last posted its quarterly earnings data on Tuesday, November 5th. The company reported $0.38 EPS for the quarter, hitting the consensus estimate of $0.38. The firm had revenue of $116.76 million for the quarter, compared to the consensus estimate of $113.00 million. Research analysts anticipate that Bowhead Specialty Holdings Inc. will post 1.38 earnings per share for the current fiscal year.
About Bowhead Specialty
(
Free Report)
Bowhead Specialty Holdings Inc provides specialty property and casualty insurance products in the United States. It underwrites casualty insurance solutions for risks in the construction, distribution, heavy manufacturing, real estate, and hospitality segments; professional liability insurance solutions for financial institutions, private and public directors and officers liability insurance, errors and omissions liability insurance, and cyber segments; and healthcare solutions for hospitals, senior care providers, managed care organizations, miscellaneous medical facilities, and healthcare management liability segments.
Further Reading
Before you consider Bowhead Specialty, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bowhead Specialty wasn't on the list.
While Bowhead Specialty currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
